By Our Insights Desk
The Indian theatrical business has seen two challenging years, in 2020 and 2021. After record box office performance in 2019, when the cumulative gross box office across languages crossed the ₹10,000 Crore mark for the first time ever, the pandemic and the associated lockdowns saw drops of more than 85% (2020) and 65% (2021) respectively, vis-à-vis the 2019 level.
At the start of 2022, there was widespread scepticism on whether the theatrical medium will be able to regain its glory, especially in wake of the rapid growth of streaming platforms in the pandemic years. Theatres being shut in most parts of India in January 2022, because of the third wave, meant that the year had a poor start, with January contributing a paltry ₹168 Crore.
But since then, things have looked progressively better, and 2022 has shaped up to be a great year at the Indian box office, second only to 2019. At ₹10,637 Crore, it finished only a fraction behind 2019, despite the January disadvantage.
Even as the Hindi film industry struggled to recover to the pre-pandemic levels, successful films from the Southern industries, especially Telugu, Kannada and Tamil, fuelled the growth. Our 2022 box office report, titled India Is Back… At The Theatres, in partnership with Group M, highlights this growth story.
You can download it here in PDF format.
Watch as a video:
For feedback and enquiries about our reports, you can email us at [email protected]
The India Box Office Report: February 2025
February 2025 emerged as a strong month at the Indian box office, grossing ₹1,245 Cr, with Chhaava alone contributing more than 50% of the amount
Ormax Cinematix's FBO: Accuracy update (February 2025)
This edition of our monthly blog summarises Ormax Cinematix's box office forecasts (FBO) for all major February 2025 releases vis-à-vis their actual box-office openings
Now streaming, at an app near you
An analysis of the streaming rights for India’s top theatrical films released between 2022 and 2024 reveals a duopolistic landscape with significant implications for the Indian theatrical industry
Subscribe to stay updated with our latest insights
We use cookies to improve your experience on this site. To find out more, read our Privacy Policy